Literature DB >> 9274533

Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma.

S Kumar-Singh1, P B Vermeulen, J Weyler, K Segers, B Weyn, A Van Daele, L Y Dirix, A T Van Oosterom, E Van Marck.   

Abstract

Angiogenesis plays an important role in the growth, progression, and metastasis of solid tumours. Malignant mesothelioma (MM) of the pleura is a highly invasive tumour with a poor prognosis. In the present study, microvascular quantification was undertaken on 25 specimens of mesothelioma and 15 specimens of non-neoplastic mesothelium (NNM), by staining for the antigens CD34 and CD31. Areas of highest intratumoural microvascular density (IMD) were identified and counted either manually (mIMD) or on a computerized image analysis system (CIAS; iIMD). The two IMDs were significantly correlated with each other (r = 0.736; P < 0.001). The average IMD for MM was significantly (P < 0.001) higher than in NNM. Moreover, each unit increment in iIMD for MM, when regarded as a continuous variable, was significantly (P = 0.001) associated with an increased hazard of about 4 per cent. When regarded as a categorical variable, the patients in the highest tertile (> 58 vessels/field) had a significantly (P < 0.01; log-rank test) shorter survival than patients in the lowest tertile (< 45 vessels/field). This association was independent of the age of the patient and of the histological type or grade of the MM. No association was noted with p53 immunoexpression. Although the mean vascular area of blood vessels measured on the CIAS did not correlate with survival, assessment of IMDs can be an important independent prognostic indicator in malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274533     DOI: 10.1002/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems.

Authors:  J G Edwards; K R Abrams; J N Leverment; T J Spyt; D A Waller; K J O'Byrne
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

2.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Authors:  Samir Kumar-Singh; Daniel Pirici; Eileen McGowan; Sally Serneels; Chantal Ceuterick; John Hardy; Karen Duff; Dennis Dickson; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.

Authors:  Samir Kumar-Singh; Patrick Cras; Rong Wang; John M Kros; Johan van Swieten; Ursula Lübke; Chantal Ceuterick; Sally Serneels; Krist'l Vennekens; Jean-Pierre Timmermans; Eric Van Marck; Jean-Jacques Martin; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.

Authors:  R Eguchi; T Nakano; I Wakabayashi
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

5.  VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

Authors:  Y Ohta; V Shridhar; R K Bright; G P Kalemkerian; W Du; M Carbone; Y Watanabe; H I Pass
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

6.  Angiogenesis is an independent prognostic factor in malignant mesothelioma.

Authors:  J G Edwards; G Cox; A Andi; J L Jones; R A Walker; D A Waller; K J O'Byrne
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

7.  Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.

Authors:  Selina Tsim; Catherine A Humphreys; Gordon W Cowell; David B Stobo; Colin Noble; Rosemary Woodward; Caroline A Kelly; Laura Alexander; John E Foster; Craig Dick; Kevin G Blyth
Journal:  Lung Cancer       Date:  2018-02-03       Impact factor: 5.705

Review 8.  Malignant pleural mesothelioma.

Authors:  H L Kindler
Journal:  Curr Treat Options Oncol       Date:  2000-10

9.  Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura.

Authors:  J G Edwards; J McLaren; J L Jones; D A Waller; K J O'Byrne
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

10.  The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma.

Authors:  Emily Pulford; James McEvoy; Ashleigh Hocking; Sarita Prabhakaran; Kim Griggs; Sonja Klebe
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.